ArticleRheumatology and therapy2024

Comparative Effectiveness of Bimekizumab and Risankizumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison.

Philip J Mease et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.